List of SBIR/STTR awards granted to Zacharon Pharmaceuticals

List of SBIR/STTR awards granted to Zacharon Pharmaceuticals

List of SBIR/STTR awards granted to Integument Technologies Inc

List of SBIR/STTR awards granted to ReyTech Corporation

List of SBIR/STTR awards granted to DULY RESEARCH, INC.

CEOs of synthetic biology companies

Founders educated at University of Malaya

where

SBIR/STTR Award Recipient

is

Zacharon Pharmaceuticals

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $114,868.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43NS054350-01A1	Phase I	114,868		sbir.gov/node/354072
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $100,000.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43CA119801-01A1	Phase I	100,000		sbir.gov/node/354070
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Zacharon Pharmaceuticals for $1,455,560.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	2R44CA119801-02	Phase II	1,455,560		sbir.gov/node/354078
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $188,112.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43CA134102-01	Phase I	188,112		sbir.gov/node/354076
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $335,739.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43NS077513-01	Phase I	335,739		sbir.gov/node/400996
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $339,513.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43NS071774-01	Phase I	339,513		sbir.gov/node/12099
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $296,236.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43NS080381-01	Phase I	296,236		sbir.gov/node/401034
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $196,245.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43CA112794-01A2	Phase I	196,245		sbir.gov/node/354074
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Zacharon Pharmaceuticals for $342,896.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	1R43NS073179-01	Phase I	342,896		sbir.gov/node/368993
	‌ ZACHARON PHARMACEUTICALS, INC. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Zacharon Pharmaceuticals for $2,998,889.0 USD from the U.S. Department of Health & Human Services.	Zacharon Pharmaceuticals			SBIR	2R44NS071774-02	Phase II	2,998,889		sbir.gov/content/substrate-optimization-therapy-novel-therapy-mucopolysaccharidosis

10 results

0 selected

10 results

0 selected